companydata.dkMedTrace Pharma A/S
CVR: 36497661
Secondary names: aQuant A/S, MedTrace A/S
Previous names: LSW MEDICAL IVS, Medtrace ApS, MedTrace A/S
The financial health of MedTrace Pharma A/S appears to be concerning, with consistent losses over recent years, including a profit of -15,355,876 DKK in 2024 despite a slight revenue decrease from 2,645,338 DKK in 2023 to 2,334,356 DKK in 2024. Revenue has shown a modest upward trend from 1,529,103 DKK in 2021 to 2,645,338 DKK in 2023, but profitability remains a significant issue, with cumulative losses totaling over 85 million DKK since 2022. The company's equity position is relatively strong at 270,064,727 DKK, indicating a solid buffer against its operational losses. However, the ongoing negative profit margins raise concerns about its sustainability and competitive position within the event equipment leasing industry.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at udvikle, kommercialisere og sælge et automatisk injektionssystem til radioaktivt vand.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 2.3 mio. | -15.4 mio. | 289.6 mio. | 270.1 mio. | 35 | |
History
Ownership
Management
Directors
Board
Production units (3)
Similar companies
Companies in the same industry and area